CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Dose Escalation Study of MLN8237, an Aurora A Kinase Inhibitor, in Adult Patients With Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck, or Gastroesophageal Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01045421
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:08.604338+00:00
Published At: 2016-08-15T00:00:00+00:00
Record Updated At: 2016-08-15
Results Posted At: 2016-08-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Advanced Nonhematological Malignancies", "Non-Small Cell Lung Cancer", "Small Cell Lung Cancer", "Metastatic Breast Cancer", "Head and Neck Squamous Cell Carcinoma", "Gastroesophageal Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-08-15"
protocolSection.identificationModule.nctId: "NCT01045421"
protocolSection.identificationModule.officialTitle: "A Phase 1 Dose Escalation Study of MLN8237, an Aurora A Kinase Inhibitor, in Adult Patients With Nonhematological Malignancies, Followed by a Phase 2 of MLN8237 in Lung, Breast, Head and Neck, or Gastroesophageal Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-08-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.